STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8
Clinical trials for STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on Hard-to-Treat cancers shows early promise
Disease control OngoingThis early-phase trial tests a combination of two drugs—trastuzumab deruxtecan (a targeted chemotherapy) and ceralasertib (which blocks a DNA repair enzyme)—in people with advanced solid tumors that have a HER2 mutation. The goal is to find the safest dose and see if the combo wo…
Matched conditions: STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:51 UTC
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThis study tests whether combining the chemotherapy drug pemetrexed with the immunotherapy drug pembrolizumab can shrink or control advanced salivary gland cancer that has returned or spread. About 45 adults with this rare cancer will receive the combination treatment. The goal i…
Matched conditions: STAGE IV MAJOR SALIVARY GLAND CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:02 UTC